Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Veradermics, Incorporated ( (MANE) ) has shared an announcement.
On May 1, 2026, Veradermics, Incorporated closed an underwritten public offering of 3,843,790 shares of common stock at $100.00 per share, and granted underwriters a 30-day option to purchase up to an additional 576,568 shares at the same price, less underwriting discounts and commissions. On the same date, the company also completed a private placement with entities affiliated with Suvretta Capital, issuing pre-funded warrants to purchase 300,000 shares of common stock at $99.99999 per warrant for gross proceeds of approximately $30.0 million, subject to customary restrictions, ownership limits, and regulatory exemptions, thereby strengthening its capital base while temporarily limiting additional equity issuance.
The most recent analyst rating on (MANE) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Veradermics, Incorporated stock, see the MANE Stock Forecast page.
More about Veradermics, Incorporated
Veradermics, Incorporated is a company that issues common stock and related equity securities to investors through public offerings and private placements. The company engages with institutional investors and underwriters in the capital markets to raise funds, utilizing instruments such as common shares and pre-funded warrants to support its corporate activities and growth plans.
Average Trading Volume: 532,521
See more data about MANE stock on TipRanks’ Stock Analysis page.